GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New capsule shows promise in brain cancer fight
Disease control Not yet recruitingThis study tests whether adding NG101m capsules to the usual treatment (radiation and chemotherapy) can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 52 adults will take part. The main goals are to check safety and see if the combination improve…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for brain cancer? experimental drug LMP744 targets recurrent glioblastoma
Disease control Not yet recruitingThis early-stage trial tests a new drug called LMP744 in 40 adults whose glioblastoma (a type of brain cancer) has come back after standard treatment. The drug is given through a vein for 5 days each month for up to a year. The goal is to see if it can shrink tumors or delay canc…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated May 11, 2026 20:49 UTC